Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells

Journal of Infectious Diseases

Volumn 210, Issue 4, 2014, Pages 646-650

  Ramirez, Lorenzo A ^a   Daniel, Alexander ^a   Frank, Ian ^a   Tebas, Pablo ^a   Boyer, Jean D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Activation; Antiretroviral therapy; Chronic inflammation; HIV 1; Influenza; H1N1; Naive T cells

Indexed keywords

ANTIRETROVIRUS AGENT; INFLUENZA VACCINE;

ADULT; AGE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INFLUENZA VACCINATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; T LYMPHOCYTE; TREATMENT RESPONSE;

ACTIVATION; ANTI-RETROVIRAL THERAPY; CD4+ T CELLS; CHRONIC INFLAMMATION; H1N1; HIV-1; INFLUENZA; NAIVE T CELLS; VACCINATION;

ADULT; AGED; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84905561206     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu132     Document Type: Article

References (15)

1. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http: //aidsinfo.nih.gov/contentfiles/ lvguidelines/adult-oi.pdf. Accessed 20 January 2014.
2. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gero 2007; 42: 432-7.
3. Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009; 30: 325-33 4.
4. Cohen JP, Macauley C. Susceptibility to influenza A in HIV-positive patients. JAMA 1989; 261: 245.
5. Neuzil KM, Coffey CS, Mitchel EF Jr, GriffinMR. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr 2003; 34: 304-7.
6. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004; 39: 609-29.
7. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet 2009; 9: 493-504.
8. Malaspina A, Moir S, Orsega SM, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005; 191: 1442-50.
9. McKittrick N, Frank I, Jacobson JM, et al. The Center for AIDS Research. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med 2013; 158: 19-26.
10. Kendal AP, Skehel JJ, Pereira MS. Concepts and procedures for laboratory- based influenza surveillance. Atlanta: Centers for Disease Control and Prevention, 1982: B17-35.
11. Hunt P, Sinclair E, Epling L, et al. T cell senescence and proliferation defects persist in treated HIV-infected individuals maintaining viral suppression and are associated with poor CD4+ T cell recovery [abstract 316]. In: Program and abstracts of the Conference on Retrovirus and Opportunistic Infections, San Francisco, CA, 16-19 February 2010.
12. Provinciali M, Moresi R, Donnini A, Lisa RM. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly. Gerentology 2009; 55: 314-21.
13. Hazenberg MD, Hamann D, Schultemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000; 1: 285-9.
14. McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176: 6333-9.
15. Centers for Disease Control and Prevention, Department of Health and Human Services. Recommended immunizations for adults-by age and by medical condition. 2013. http: //www.cdc.gov/vaccines/schedules/ downloads/adult/adult- schedule-easy-read-bw.pdf. Accessed 7 October 2013.